Tianda Pharmaceuticals Limited (0455.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 277.36M |
| Enterprise Value | 345.21M |
| P/E Ratio | -6.08 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 1.2 |
| Price/Book Ratio | 0.49 |
| Enterprise/Revenue | 1.56 |
| Enterprise/EBITDA | -42.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.11 |
AD
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.08 |
Income Statement
| Revenue | 322.95M |
| Revenue/Share | 0.09 |
| Gross Profit | 133.31M |
| EBITDA | -24.41M |
| Net Income | -70M |
| Diluted EPS | -0.03 |
Balance Sheet
| Total Cash | 64.81M |
| Total Cash/Share | 0.03 |
| Total Debt | 132.66M |
| Total Debt/Equity | 0.29 |
| Current Ratio | 0.83 |
| Book Value Per Share | 0.21 |
Price History
| 52-Week Change | -37.35 |
| 52-Week High | 0.22 |
| 52-Week Low | 0.08 |
| Moving Average 50 Days | 0.09 |
| Moving Average 200 Days | 0.11 |
Statistics
| Average Volume | 63,645 |
| Shares Outstanding | 2.15B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.09 |
| Last Split Factor | 1447:1000 |
| Last Split Date | July 08, 2010 |
AD
